Mediracer receives US FDA clearance for Mediracer NCS device

  Mediracer is preparing to enter the US market after the US Food and Drug Administration (FDA) 510(k) review for premarket notification for the Mediracer® NCS device was successfully completed (SE) and clearance to market the device in the US was granted. The...
College of Podiatry Conference 2019

College of Podiatry Conference 2019

We are proud to assist The College of Podiatry Conference with our distributor Henry Schein The College of Podiatry Conference en Reino Unido es uno de los eventos más importantes del año para los podiatras en UK y el mundo. En 2018, más de 1.350 podiatras asistieron...
College of Podiatry Conference 2019

College of Podiatry Conference 2019

We are proud to assist The College of Podiatry Conference with our distributor Henry Schein The College of Podiatry Conference is one of the most important events of the year for podiatrists. In 2018 over 1,350 colleagues attended and profited from the latest...

El sistema Mediracer® NCS completó con éxito la inspección FDA 510(k)

El sistema de Mediracer podrá ser utilizado en el mercado de Estados Unidos para ayudar a diagnósticos y evaluaciones precisas y objetivas con estudios de la conducción nerviosa NCS para el Síndrome del Túnel carpiano y la Neuropatía Diabética. Esto es posible después...